Charles Craig

4PUBLICATIONS
1CO-AUTHORS
Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 03, 2021
V3-Loop genotypes do not predict maraviroc susceptibility of CCR5-tropic virus or clinical response through week 48 in HIV-1-infected, treatment-experienced persons receiving optimized background regimens.

M E Lewis, P Simpson, J Mori

|Jun 23, 2021
Highly prevalent Russian HIV-1 V3-loop sequence variants are susceptible to maraviroc.

M E Lewis, B Jubb, P Simpson

|Dec 21, 2019
Incidence of CXCR4 tropism and CCR5-tropic resistance in treatment-experienced participants receiving maraviroc in the 48-week MOTIVATE 1 and 2 trials.

Becky Jubb, Marilyn Lewis, Lynn McFadyen

|Dec 27, 2018
Clonal analysis of HIV-1 genotype and function associated with virologic failure in treatment-experienced persons receiving maraviroc: Results from the MOTIVATE phase 3 randomized, placebo-controlled trials.

Marilyn Lewis, Julie Mori, Jonathan Toma

Pageof 1

Frequent Collaborators

2 joint publications

E van der Ryst